Posted on: November 28, 2019 Posted by: earlenehands Comments: 0

Dr. Malhotra on Pembrolizumab During Concurrent Chemoradiation in NSCLC



Jyoti Malhotra, MD, MPH, medical oncologist, Rutgers Cancer Institute of New Jersey, and assistant professor of medicine, Robert Wood Johnson Medical School, Rutgers University, discusses a phase I multicenter trial of PD-1 blockade with pembrolizumab (Keytruda) with concurrent chemoradiation in patients with locally advanced, unresectable non–small cell lung cancer (NSCLC).

To learn more, visit our website or social media pages:

Website:
Twitter:
Facebook:
LinkedIn:

source: https://medinaportal.net

Xem thêm các bài viết về Sức Khỏe: https://medinaportal.net/category/suc-khoe/

Categories:

Leave a Comment